Episode # 297 • 07 Apr 2026
How Prostate Artery Embolization Optimizes Radiation Outcomes
What role does prostate artery embolization (PAE) play in modern prostate cancer care? In this episode of BackTable Urology, Dr. Nainesh Parikh (Interventional Radiology at Moffitt Cancer Center) and Dr. Kosj Yamoah (Radiation Oncology at Moffitt Cancer Center) join Dr. Ruchika Talwar (Vanderbilt University) to discuss how PAE could become a key adjunct in optimizing radiation therapy outcomes.
Timestamps
00:00 - Introduction
01:44 - Why Use PAE in Cancer
04:08 - Neoadjuvant and Salvage Use
07:26 - Radiation Planning Benefits
12:51 - PAE vs. Surgery
18:36 - SBRT Access
20:48 - Current Evidence and Trials
25:29 - Patient Selection
32:18 - PAE After Radiation
36:56 - When to Avoid PAE
40:29 - Long-Term Implications
44:28 - Conclusions
Resources
You may also like
More about this episode
They review how PAE can improve lower urinary tract symptoms and reduce prostate volume, potentially optimizing patients for radiation therapy, including stereotactic body radiotherapy (SBRT) and brachytherapy. The discussion highlights early clinical data and patient selection considerations such as gland size and symptom burden. Finally, they examine post-radiation applications, technical challenges, and current limitations, emphasizing the need for larger, multicenter trials to better define PAE’s role in prostate cancer treatment pathways.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.